PetMed AI

4.8 · Veterinary Study Companion
GET
Real-World ScenariosReal-World Case Study

My Senior Dog Is Panting at Night and Coughing — Is It His Heart?

An 11-year-old Cavalier King Charles Spaniel with nocturnal cough, exercise intolerance, SRR 40/min. MMVD, ACVIM staging, treatment cascade, and breed predisposition.

9 min read2025-10-27
dog coughing night heart diseasedog heart failureolder dog pantingcardiac cough
PetMed AI Veterinary TeamVerified

Reviewed by Licensed DVM Professionals

Evidence-BasedPeer-Reviewed SourcesLast updated: 2025-10-27
Case Presentation

Your 11-year-old Cavalier King Charles Spaniel, Winston, has had a cough for about 3 weeks. It's worse at night and when he's resting. He tires more easily on walks. You counted his breaths while he slept: 40 per minute. You've read that could mean heart disease. Is it?

11 yr
Age
CKCS
Breed
3 wk
Cough Duration
40/min
Sleep Resp. Rate

🫀 MMVD: #1 Acquired Heart Disease in Dogs

Myxomatous mitral valve disease (MMVD) is the most common acquired heart disease in dogs. The mitral valve thickens and degenerates, leading to regurgitation, left atrial enlargement, and eventually congestive heart failure (CHF).

Small breeds are overrepresented — Cavalier King Charles Spaniels have one of the highest prevalences, with many affected by 10 years of age. The cough and nocturnal panting can indicate pulmonary edema (fluid in the lungs) from left-sided heart failure.

Red Flag: Nocturnal cough + panting + exercise intolerance in a senior small-breed dog = cardiac disease until proven otherwise. This combination warrants urgent veterinary evaluation.

ACVIM Staging (A through D)

The American College of Veterinary Internal Medicine (ACVIM) classifies MMVD into four stages, each guiding treatment decisions:

Stage Description Treatment
A At risk (predisposed breed, no structural changes) No treatment — monitor
B1 Murmur present, no cardiac enlargement Annual monitoring, echocardiography
B2 Murmur + cardiac enlargement on imaging Pimobendan (Vetmedin) — delays CHF onset
C Past or current congestive heart failure Furosemide + Pimobendan + ACE inhibitor
D Refractory CHF (not responding to standard therapy) Intensified diuretics, add-on drugs, specialist referral

Winston's cough and elevated sleeping respiratory rate of 40/min suggest he may be in Stage C — active congestive heart failure. The Cardiology Specialist can walk you through the staging criteria and treatment cascade.


😴 Sleeping Respiratory Rate Monitoring

Sleeping respiratory rate (SRR) is the simplest and most powerful way to monitor heart failure at home. Here's how:

1

Wait for Deep Sleep

Make sure your dog is in a relaxed, deep sleep — not just resting. The chest should rise and fall steadily.

2

Count for 60 Seconds

Count the number of chest rises in a full 60 seconds. Each rise = one breath. Alternatively, count for 30 seconds and multiply by 2.

3

Record Daily

Track SRR daily at the same time. A rising trend may indicate worsening heart failure even before clinical signs change.

<30
Normal SRR/min
30-40
Borderline — Monitor
>40
See Your Vet

Consistently above 40 breaths per minute during sleep suggests pulmonary edema and warrants a veterinary visit. The Cough Audio Analyzer can help document cough patterns — useful for distinguishing cardiac cough from other causes like tracheal collapse or bronchitis.


Treatment Cascade for Stage C Heart Failure

When a dog enters Stage C (active CHF), treatment focuses on three pillars:

1

Furosemide (Diuretic)

Reduces pulmonary edema by promoting fluid excretion. Dose is titrated to effect — too little won't resolve fluid, too much causes dehydration and kidney stress. Most dogs start at 2-4 mg/kg PO q12h and adjust based on SRR and clinical response.

2

Pimobendan (Vetmedin)

An inodilator that improves cardiac contractility and causes vasodilation. The EPIC trial showed it delays CHF onset when started at Stage B2. At Stage C, it's a cornerstone of therapy at 0.25-0.3 mg/kg PO q12h.

3

ACE Inhibitor (Enalapril or Benazepril)

Reduces afterload by blocking the renin-angiotensin-aldosterone system (RAAS). Typical dose: 0.5 mg/kg PO q12-24h. Monitor renal values (BUN/creatinine) after initiation.

The Drug Formulary provides dosing references for all three medications. Echocardiography confirms the diagnosis and guides staging — treatment should always be prescribed and monitored by a veterinarian.


🐶 Breed Predisposition: Cavalier King Charles Spaniels

Cavaliers have a genetic predisposition to MMVD — it is often inherited as a polygenic trait. Key facts:

  • Many Cavaliers develop a murmur by 5-6 years of age
  • By age 10, the majority will have some degree of MMVD
  • Breed-specific screening (echocardiography) can identify early changes
  • The EPIC trial demonstrated that early pimobendan at Stage B2 delays CHF onset by approximately 15 months
  • Other predisposed breeds include: Dachshunds, Miniature Poodles, Chihuahuas, and Miniature Schnauzers

The Breed Scanner identifies breed-specific health predispositions, including cardiac risks.


Key Takeaways
  • MMVD is the #1 acquired heart disease in dogs — Cavalier King Charles Spaniels are at the highest risk.
  • ACVIM staging (A-D) guides treatment decisions. Stage C = active CHF requiring furosemide + pimobendan + ACE inhibitor.
  • Sleeping respiratory rate >40/min during sleep strongly suggests pulmonary edema — see your vet urgently.
  • Nocturnal cough + panting + exercise intolerance in a senior small breed = cardiac until proven otherwise.
  • The EPIC trial showed pimobendan at Stage B2 delays CHF onset by ~15 months — early detection matters.
  • PetMed AI tools support education and monitoring — echocardiography and treatment decisions require a veterinarian.

Continue Learning with PetMed AI

Every tool mentioned in this article is available in the app. Start exploring for free.

15 AI Vision Labs
25 Specialist Chatbots
15 Clinical Tools
4.8on App Store

Download on the

App Store

PetMed AI

GET — Free